Lilly Falls on Oral Obesity Pill as FDA Decision Looms
Eli Lilly stock fell about 5% as investors awaited the FDA's April decision on orforglipron. Novo Nordisk's intensifi...
Discover key insights every first time investor should know. Equip yourself with the knowledge for a successful and rewarding investing experience.
28,352 articlesEli Lilly stock fell about 5% as investors awaited the FDA's April decision on orforglipron. Novo Nordisk's intensifi...
In 2026, XLK’s cap-driven approach has quietly outpaced FTEC. Concentration limits are redirecting capital toward sem...
In Q1 2026, Alphabet leverages cloud and AI families to expand, while Meta doubles down on ads. The split underscores...
Microsoft reveals a $37 billion annualized AI run rate for Q3 2026, underscoring AI's rapid monetization and the scal...
Top tech leaders warn that giving AI labs access to sensitive business data may erode competitive advantages. The iss...
Caterpillar—a 100-year-old icon in heavy equipment—is redefining its path by embracing AI-enabled infrastructure, dat...
A major crypto development is sending ripples through the market as Ethereum reacts to optimistic signals from Iran a...
Wells Fargo lowers Amazon's price target to $312 while keeping an Overweight rating, highlighting AWS as the core eng...
Investors greeted a policy-driven pact between Apple and Intel, sending intel shares leap after the announcement and ...
A volatile day in the stock market today, july features a notable drop for Eos Energy after project news. Learn what ...
XRP rallied on whispers of regulatory clarity, but the price action is tempered by cautious charts. This deep dive ex...
As Deere (DE) releases its 2026 earnings outlook, investors weigh crop cycles, equipment demand, and margin trends. T...